Learn More
Lung cancer is presently the most commonly diagnosed metastatic tumor and the leading cause of cancer-related deaths worldwide. Moreover, drug resistance occurs frequently in lung cancer patients. There is an urgent need for developing promising anticancer drugs to improve overall survival of patients with lung cancer. In our recent antitumor drug discovery(More)
  • 1